Incorporating ePrognosis to Encourage "Smarter Screening" for Breast and Colorectal Cancer in Older Adults
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 75
- 试验地点
- 2
- 主要终点
- Percentage of participants enrolled at 6 months
研究概览
简要总结
This clinical trial assesses the feasibility and acceptability of a smarter screening intervention for breast and colorectal cancer in older adults. This study aims to learn more about how to support patients and physicians in making cancer screening decisions for older adults.
详细描述
PRIMARY OBJECTIVES:
I. Complete development of and refine "Smarter Screening", a multi-component, patient-centered intervention centered around ePrognosis: Cancer Screening to facilitate shared decision-making screening discussions for breast and colorectal cancer in older adults.
II. Assess feasibility and acceptability of the "Smarter Screening" intervention and assess its impact versus usual care on shared decision-making about whether or not to continue breast and colorectal cancer (CRC) screening among multi-ethnic and socioeconomically diverse primary care patients.
EXPLORATORY OBJECTIVES:
I. Impact on breast and CRC screening versus usual care.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 70 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age 70 years and above
- •Ability to understand study procedures and to comply with them for the entire length of the study
- •Ability of individual to understand a written informed consent document, and the willingness to sign it
- •Have no prior history of cancer
- •Scheduled for an upcoming appointment in University of California, San Francisco (UCSF) General Internal Medicine or Women's Health Primary Care clinics
- •English-speaking
排除标准
- •Contraindication to any study-related procedure or assessment
- •Non-English speaking
- •Are under the current medical care of either the study primary investigator (PI) or co-investigator (Co-I)
结局指标
主要结局
Percentage of participants enrolled at 6 months
时间窗: 6 months
The investigators aim to attain at least 75% of recruited patients in each arm at the 6 month follow-up.
Proportion of participants enrolled
时间窗: 6 months
Ability to successfully recruit the target of approximately 40 patients will be determined by the overall number of participants who were screened for enrollment compared to the overall number of participants who were randomized to one of the groups.
Proportion of participants who received an ePrognosis report
时间窗: 6 months
The proportion of participants who received an ePrognosis report will be reported
Responses to Qualitative Acceptability survey
时间窗: 6 months
A survey will be provided to PCPs and used to measure acceptability of the ePrognosis report by asking patients and providers to provide feedback about the intervention, including likes and dislikes, and future recommendation of using the report provided.
Proportion of primary care physicians (PCPs) enrolled
时间窗: 6 months
Ability to successfully recruit PCPs will be determined by the overall number of physicians who were contacted compared to the overall number of physicians who actively participated over the course of the study.
Proportion of physicians who utilized the ePrognosis clinician report
时间窗: 6 months
All enrolled intervention PCPs will receive a web-based survey after each patient visit to record whether the physicians used and/or discussed ePrognosis in that visit. The proportion of physicians who use the ePrognosis clinician report in their cancer screening counseling with participants/patients will be reported
次要结局
未报告次要终点